Sort
15,273 grants matching “antimicrobial resistance”
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics
$431,997Ann R Falsey · University Of Rochester · R01 · FY2010 · AI
Task X11: Product Development Plans and Feasibility Assessments
$431,854James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Type VI secretion effectors and interbacterial competition in vivo
$431,794Joseph David Mougous · University Of Washington · R01 · FY2014 · AI
Mechanisms of cannabinoid-resistance among oral spirochetes
$431,750David A Scott · University Of Louisville · R21 · FY2025 · DE
Vaccine-mediated control of bacterial virulence regulation and infection
$431,724Pamela Ranel Hall · University Of New Mexico Health Scis Ctr · R01 · FY2020 · AI
Molecular targets in peptidoglycan synthesis
$431,711Christopher Davies · Medical University Of South Carolina · R01 · FY2017 · GM
Mechanisms of multi-species bacterial interactions
$431,450Anupama Khare · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Controlling Catheter-Associated Urinary Tract Infections Using Smart Catheters with Rationally Designed Active Topographies
$431,274Dacheng Ren · Syracuse University · R01 · FY2023 · EB
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis
$431,169Juhi Bagaitkar · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · DE
Malaria Topoisomerase inhibitors
$431,121Pradipsinh K. Rathod · University Of Washington · R01 · FY2016 · AI
Malaria Topoisomerase inhibitors
$431,121Pradipsinh K. Rathod · University Of Washington · R01 · FY2017 · AI
ALTERNATIVE APPROACHES FOR E FAECALIS INFECTIONS
$431,005Barbara E Murray · University Of Texas Hlth Sci Ctr Houston · R37 · FY2006 · AI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?
$430,862Suzanne L. Walker · Harvard Medical School · R01 · FY2010 · GM
Molecular determinants of oxidative stress in Salmonella pathogenesis
$430,833Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2020 · AI
BIOSYNTHESIS OF MYCOBACTERIAL DIMYCOCEROSATE ESTER VIRULENCE FACTORS
$430,689Luis E Quadri · Brooklyn College · R15 · FY2014 · AI
Phage resistance and mobile genetic elements in Vibrio cholerae
$430,577Kimberley Diane Seed · University Of California Berkeley · R01 · FY2017 · AI
Human Immunomics & Trained Immunity in Persistent Candidemia
$430,558Elaine F Reed · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2025 · AI
Exposure heterogeneity & environmental transmission dynamics of Escherichia coli
$430,341Cristina Lanzas · North Carolina State University Raleigh · R01 · FY2017 · GM
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
$430,192Julian A Simon · Fred Hutchinson Cancer Research Center · R01 · FY2013 · DC
Secreted antimicrobial proteins of the intestinal Bacteriodales
$430,190Laurie E Comstock · Brigham And Women'S Hospital · R01 · FY2017 · AI
Secreted antimicrobial proteins of the intestinal Bacteriodales
$430,190Laurie E Comstock · Brigham And Women'S Hospital · R01 · FY2019 · AI
Bacterial Interference to Prevent Staphylococcus aureus Infection
$430,030Paul J Planet · Children'S Hosp Of Philadelphia · R01 · FY2019 · AI
Development of RC-101 as an Intravaginal Anti-HIV-1 Topical Microbicide
$430,020Alexander M Cole · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI
Heme utilization and homeostasis in Pseudomonas aeruginosa
$430,013Angela None Wilks · University Of Maryland Baltimore · R01 · FY2017 · AI
Secreted antimicrobial proteins of the intestinal Bacteriodales
$429,853Laurie E Comstock · Brigham And Women'S Hospital · R01 · FY2018 · AI